Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.05 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.12 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |